Diabetes insipidus: Clinical sciences

1,214views

Diabetes insipidus: Clinical sciences

G3n3tics to add

G3n3tics to add

Legg-Calve-Perthes disease
1p36 deletion syndrome: Year of the Zebra
Cleidocranial dysplasia
Developmental dysplasia of the hip: Clinical sciences
Collagen disorders: Pathology review
Approach to connective tissue disorders: Clinical sciences
Fetal alcohol syndrome
Rett syndrome
Approach to a child with Down syndrome (trisomy 21): Clinical sciences
Approach to aneuploidies and microdeletions: Clinical sciences
Approach to inborn errors of metabolism (acute): Clinical sciences
Approach to inborn errors of metabolism (progressive or chronic): Clinical sciences
Approach to neurocutaneous syndromes: Clinical sciences
Approach to prenatal teratogen exposure: Clinical sciences
Approach to primary immunodeficiencies: Clinical sciences
Cystic fibrosis and primary ciliary dyskinesia: Clinical sciences
Sickle cell disease: Clinical sciences
Developmental milestones (newborn and infant): Clinical sciences
Developmental milestones (toddler): Clinical sciences
Developmental milestones (childhood): Clinical sciences
Approach to atypical genitalia: Clinical sciences
Approach to delay or regression in developmental milestones: Clinical sciences
Approach to delayed puberty: Clinical sciences
Approach to feeding and eating disorders: Clinical sciences
Approach to growth faltering: Clinical sciences
Approach to hypotonia (newborn and infant): Clinical sciences
Approach to neurodevelopmental disorders: Clinical sciences
Approach to poor feeding (newborn and infant): Clinical sciences
Approach to precocious puberty: Clinical sciences
Approach to primary amenorrhea: Clinical sciences
Approach to short stature: Clinical sciences
Obesity (pediatrics): Clinical sciences
Congenital cytomegalovirus (NORD)
Chiari malformation
Seizures and epilepsy
Approach to epilepsy: Clinical sciences
Febrile seizure (pediatrics): Clinical sciences
Early infantile epileptic encephalopathy (NORD)
Spinocerebellar ataxia (NORD)
Sturge-Weber syndrome
Spina bifida
Von Hippel-Lindau disease: Year of the Zebra 2024
Neurocutaneous disorders: Pathology review
Human development days 1-4
Human development days 4-7
Human development week 2
Human development week 3
Development of the digestive system and body cavities
Development of the fetal membranes
Development of the placenta
Development of the umbilical cord
Development of twins
Hedgehog signaling pathway
Ectoderm
Endoderm
Mesoderm
Development of the cardiovascular system
Fetal circulation
Development of the eye
Development of the gastrointestinal system
Development of the teeth
Development of the tongue
Development of the axial skeleton
Development of the limbs
Development of the muscular system
Development of the renal system
Development of the reproductive system
Development of the respiratory system
Peutz-Jeghers syndrome
Autism spectrum disorder
Autism spectrum disorder: Clinical sciences
Developmental and learning disorders: Pathology review
Learning disability
von Hippel-Lindau disease
Muscular dystrophies and mitochondrial myopathies: Pathology review
Fatty acid oxidation
Fatty acid synthesis
Classical homocystinuria (NORD)
Homocystinuria
Alkaptonuria
Cystinuria (NORD)
Hartnup disease
Maple syrup urine disease
Ornithine transcarbamylase deficiency
Phenylketonuria (NORD)
Essential fructosuria
Galactosemia
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Hereditary fructose intolerance
Lactose intolerance
Pyruvate dehydrogenase deficiency
Abetalipoproteinemia
Familial hypercholesterolemia
Hyperlipidemia
Hypertriglyceridemia
Glycogen storage disease type I
Glycogen storage disease type II (NORD)
Glycogen storage disease type III
Glycogen storage disease type IV
Glycogen storage disease type V
Mucopolysaccharide storage disease type 1 (Hurler syndrome) (NORD)
Mucopolysaccharide storage disease type 2 (Hunter syndrome) (NORD)
Fabry disease (NORD)
Gaucher disease (NORD)
Krabbe disease
Leukodystrophy
Metachromatic leukodystrophy (NORD)
Niemann-Pick disease type C
Niemann-Pick disease types A and B (NORD)
Tay-Sachs disease (NORD)
Cystinosis
Disorders of amino acid metabolism: Pathology review
Disorders of carbohydrate metabolism: Pathology review
Disorders of fatty acid metabolism: Pathology review
Dyslipidemias: Pathology review
Glycogen storage disorders: Pathology review
Lysosomal storage disorders: Pathology review
Hypothyroidism: Pathology review
Hypothyroidism
Approach to hypothyroidism: Clinical sciences
Hypothyroidism medications
Hyperthyroidism medications
Approach to hyperthyroidism and thyrotoxicosis: Clinical sciences
Hyperthyroidism
Hyperthyroidism: Pathology review
Hashimoto thyroiditis: Clinical sciences
Thyroid nodules: Clinical sciences
Multiple endocrine neoplasia: Pathology review
Disorders of sex chromosomes: Pathology review
Disorders of sexual development and sex hormones: Pathology review
Hypopituitarism: Pathology review
Growth hormone deficiency
Congenital adrenal hyperplasia
Atrial septal defect
Coarctation of the aorta
Patent ductus arteriosus
Ventricular septal defect
Hypoplastic left heart syndrome
Tetralogy of Fallot
Total anomalous pulmonary venous return
Transposition of the great vessels
Persistent truncus arteriosus
Cyanotic congenital heart defects: Pathology review
Acyanotic congenital heart defects: Pathology review
Congenital renal disorders: Pathology review
Congenital gastrointestinal disorders: Pathology review
Congenital neurological disorders: Pathology review
Congenital TORCH infections: Pathology review
Approach to congenital heart diseases (cyanotic): Clinical sciences
Approach to congenital heart diseases (acyanotic): Clinical sciences
Introduction to the immune system
MHC class I and MHC class II molecules
VDJ rearrangement
Antibody classes
Ataxia-telangiectasia
DiGeorge syndrome
Wiskott-Aldrich syndrome
X-linked agammaglobulinemia
Selective immunoglobulin A deficiency
Isolated primary immunoglobulin M deficiency
Adenosine deaminase deficiency
Hyper IgM syndrome
Complement deficiency
Chronic granulomatous disease
Leukocyte adhesion deficiency
Thymic aplasia
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Cornelia de Lange syndrome: Year of the Zebra
Alagille syndrome (NORD): Year of the Zebra
Alkaptonuria: Year of the Zebra
Alpha-1 antitrypsin deficiency: Year of the Zebra 2024
Chopra-Amiel-Gordon syndrome: Year of the Zebra 2024
FOXG1 syndrome: Year of the Zebra
Gaucher disease (NORD): Year of the Zebra
Gorlin syndrome: Year of the Zebra
Leprosy: Year of the Zebra
Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: Year of the Zebra
Nail-patella syndrome: Year of the Zebra
PGAP3-congenital disorder of glycosylation: Year of the Zebra
Phenylketonuria (NORD): Year of the Zebra
Pierre Robin sequence: Year of the Zebra
Retroperitoneal fibrosis: Year of the Zebra
Sanfilippo syndrome: Year of the Zebra
Shwachman-Diamond syndrome: Year of the Zebra
Turner syndrome: Year of the Zebra
Andersen-Tawil syndrome: Year of the Zebra 2025
Peroxisomal disorders: Pathology review
Cytoskeleton and elastin disorders: Pathology review
Epidermolysis bullosa: Year of the Zebra
Gorlin syndrome (Gorlin Syndrome Alliance)
Antepartum care (first trimester): Clinical sciences
Antepartum care (second trimester): Clinical sciences
Antepartum care (third trimester): Clinical sciences
Fetal aneuploidy screening: Clinical sciences
Intrapartum care (1st, 2nd, 3rd, and 4th stages): Clinical sciences
Cystic fibrosis: Pathology review
Autosomal trisomies: Pathology review
Miscellaneous genetic disorders: Pathology review
Gastroschisis
Omphalocele
Approach to abdominal wall defects: Clinical sciences
Early pregnancy loss: Clinical sciences
Pyloric stenosis: Clinical sciences
Pyloric stenosis
Esophageal atresia and tracheoesophageal fistula: Year of the Zebra
Intestinal atresia
Hirschsprung disease
Hirschsprung disease: Year of the Zebra
Alagille syndrome (NORD)
Renal agenesis
Bladder exstrophy
Horseshoe kidney
Hypospadias and epispadias
Potter sequence
Posterior urethral valves
Renal tubular acidosis
Parathyroid disorders and calcium imbalance: Pathology review
Diabetes insipidus
Diabetes insipidus: Clinical sciences
Breast cancer: Pathology review
Breast cancer
Breast cancer screening: Clinical sciences
Colorectal polyps and cancer: Pathology review
Neuroendocrine tumors of the gastrointestinal system: Pathology review
Familial adenomatous polyposis
Multiple endocrine neoplasia: Clinical sciences
Fanconi anemia: Year of the Zebra 2025
Desmoid Tumor (NORD)
Multiple endocrine neoplasia
Oncogenes and tumor suppressor genes
Necrosis and apoptosis
Charcot-Marie-Tooth disease
Spinal muscular atrophy
Precocious puberty
Delayed puberty
5-alpha-reductase deficiency
Androgen insensitivity syndrome
Kallmann syndrome
Puberty and Tanner staging
Amenorrhea
Hydronephrosis
Beta-thalassemia: Year of the Zebra
Alpha-thalassemia
Beta-thalassemia
Von Willebrand disease
Protein S deficiency
Factor V Leiden
Protein C deficiency
Antithrombin III deficiency
Zellweger spectrum disorders (NORD)
Glycogen metabolism
Hemochromatosis: Clinical sciences
Lesch-Nyhan syndrome
Purine and pyrimidine synthesis and metabolism disorders: Pathology review
Adrenoleukodystrophy (NORD)
Alzheimer disease: Clinical sciences
Alzheimer disease

Decision-Making Tree

Transcript

Watch video only

Diabetes insipidus, or DI for short, is a type of polyuria-polydipsia syndrome, meaning increased fluid intake and urination, specifically resulting in more than 3 liters per day of dilute urine. The most common cause of polyuria-polydipsia syndrome is diabetes mellitus; but three other causes include diabetes insipidus, which can be central or nephrogenic; and primary polydipsia. In central DI, the pituitary doesn’t make enough vasopressin, also called antidiuretic hormone or ADH for short, which normally increases water reabsorption in the kidneys; while with nephrogenic DI, the kidneys don’t respond to vasopressin.

Finally, in primary polydipsia, there’s increased fluid intake, which naturally suppresses vasopressin secretion.

Now, if your patient presents with a chief concern suggesting diabetes insipidus, first, perform an ABCDE assessment to determine if they’re unstable or stable.

If unstable, stabilize their airway, breathing, and circulation. Next, obtain IV access and put your patient on continuous vital sign monitoring, including blood pressure, heart rate, and pulse oximetry. Finally, if needed, provide supplemental oxygen.

Now, here’s a clinical pearl! In most cases, patients with diabetes insipidus can compensate for the fluid loss through increased fluid intake. However, individuals who aren’t able to drink fluids, like those with impaired regulatory thirst mechanisms or impaired consciousness, can develop severe dehydration and hyperosmolality! Severe dehydration can cause hypotension, renal hypoperfusion, subsequent tubular necrosis, and even shock.

On the flip side, hyperosmolality leads to an osmotic shift of intracellular fluid toward the extracellular space, causing neurons in the brain to become dehydrated. Eventually, this causes various neurologic manifestations, including irritability, seizures, and even coma. Now, let’s go back to the ABCDE assessment and take a look at stable patients.

In this case, obtain a focused history and physical examination. Most patients will compensate for the fluid loss through increased fluid intake, so the typical presentation will include a patient who reports symptoms associated with polyuria, such as urinary frequency, nocturia, and enuresis. Additionally, they’ll report excessive thirst and increased fluid intake!

In some individuals, history might reveal recent neurosurgery, head trauma, lithium use, or a family history of diabetes insipidus.

On the other hand, there are no signs of dehydration on the physical exam since patients compensate by increased fluid intake! In other words, most of your patients will have normal skin turgor and moist mucous membranes! With these findings, you should suspect polyuria-polydipsia syndrome.

Your next step is to obtain a fingerstick glucose level to rule out diabetes mellitus. If that’s ruled out, obtain the patient’s 24-hour urine output on unrestricted fluid intake, and order labs, including urine and plasma osmolality, as well as serum sodium.

First, assess the 24-hour urine output. If it’s less than 50 milliliters per kilogram of body weight, you can rule out polyuria and consider alternative diagnoses.

On the other hand, if urine output is greater than 50 milliliters per kilogram, you are dealing with polyuria.

Next, you should assess urine osmolality (Uosm), meaning how concentrated the urine is. If urine osmolality is higher than 800 milliosmoles per kilogram, that suggests concentrated urine, so consider alternative diagnoses.

However, if urine osmolality is less than 800 milliosmoles per kilogram, that suggests dilute urine, so polyuria-polydipsia syndrome!

Next, assess serum sodium levels and plasma osmolality.

If serum sodium is 135 millimoles per liter or less, and plasma osmolality is 280 milliosmoles per kilogram or less, you can diagnose primary polydipsia!
Management involves restricting fluid intake and addressing the underlying cause. For example, if it’s associated with psychiatric conditions, you should consult your psychiatry team and consider appropriate therapies.

But, in most individuals, serum sodium and plasma osmolality are normal, so be sure to order the water deprivation test to determine the exact cause of polyuria-polydipsia syndrome!

To perform this test, first, restrict the patient’s fluid intake over a prolonged period of time, typically up to 17 hours, and check the urine osmolality every 1 to 2 hours. Normally, fluid restriction stimulates vasopressin secretion, increasing water reabsorption in the kidneys, which concentrate the urine and increase osmolality!

So, if upon water deprivation, urine osmolality increases over 800 milliosmoles per kilogram, the patient’s ability to concentrate urine is normal, so you can diagnose primary polydipsia.

Even though this case is mild, management also relies on restricting free water intake and addressing the underlying cause of excessive fluid intake.

Finally, if the urine osmolality remains below 300 milliosmoles per kilogram, your patient’s ability to concentrate the urine is impaired, so diagnose diabetes insipidus.

Sources

  1. "SOCIETY FOR ENDOCRINOLOGY CLINICAL GUIDANCE: Inpatient management of cranial diabetes insipidus. " Endocr Connect. (2018;7(7):G8-G11. )
  2. "Diabetes insipidus. " Nat Rev Dis Primers. (2019;5(1):54. Published 2019 Aug 8. )
  3. "Diabetes insipidus. " Presse Med. (2021;50(4):104093.)
  4. "Diagnosis and management of diabetes insipidus for the internist: an update. " J Intern Med. (2021;290(1):73-87. )
  5. "Diagnostic Testing for Diabetes Insipidus. In: Feingold KR, Anawalt B, Blackman MR, et al., eds. " Endotext. South Dartmouth (MA): MDText.com, Inc. (November 28, 2022. )
  6. "Polyuria-polydipsia syndrome: a diagnostic challenge. " Intern Med J. (2018;48(3):244-253. )
  7. "Diagnosis and differential diagnosis of diabetes insipidus: Update. " Best Pract Res Clin Endocrinol Metab. (2020;34(5):101398. )
  8. "Diagnosis and Management of Central Diabetes Insipidus in Adults. " J Clin Endocrinol Metab. (2022;107(10):2701-2715.)